Completed Access to Information Requests

Follow:

  • RSS
  • Cite

    Cite

    APA

    Open Government - Government of Canada. (2017, December 10). Completed Access to Information Requests. Retrieved from http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3AAgriculture%20and%20Agri-Food%20Canada&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3ASocial%20Sciences%20and%20Humanities%20Research%20Council%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ANational%20Film%20Board&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3AThe%20Correctional%20Investigator%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AOffice%20of%20the%20Commissioner%20of%20Lobbying%20of%20Canada&ati%5B0%5D=%3AGlobal%20Affairs%20Canada&ati%5B1%5D=%3ANational%20Research%20Council%20Canada&ati%5B2%5D=%3AOffice%20of%20the%20Information%20Commissioner%20of%20Canada&ati%5B3%5D=%3APublic%20Safety%20Canada&ati%5B4%5D=ati_month_en%3AMarch&ati%5B5%5D=ati_organization_en%3AHealth%20Canada&ati%5B6%5D=ati_organization_en%3ANational%20Defence&ati%5B7%5D=ati_organization_en%3ANational%20Film%20Board&ati%5B8%5D=ati_organization_en%3AWestern%20Economic%20Diversification%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&page=8
    MLA

    “Completed Access to Information Requests.” Open Government - Government of Canada, 10 December 2017, http://open.canada.ca/en/search/ati?f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&amp%3Bamp%3Bf%5B1%5D=ss_ati_organization_en%3AAgriculture%20and%20Agri-Food%20Canada&amp%3Bamp%3Bf%5B2%5D=ss_ati_organization_en%3ASocial%20Sciences%20and%20Humanities%20Research%20Council%20of%20Canada&amp%3Bamp%3Bati%5B0%5D=ss_ati_organization_en%3ANational%20Film%20Board&amp%3Bamp%3Bati%5B1%5D=ss_ati_organization_en%3AThe%20Correctional%20Investigator%20Canada&amp%3Bati%5B0%5D=ss_ati_organization_en%3AOffice%20of%20the%20Commissioner%20of%20Lobbying%20of%20Canada&ati%5B0%5D=%3AGlobal%20Affairs%20Canada&ati%5B1%5D=%3ANational%20Research%20Council%20Canada&ati%5B2%5D=%3AOffice%20of%20the%20Information%20Commissioner%20of%20Canada&ati%5B3%5D=%3APublic%20Safety%20Canada&ati%5B4%5D=ati_month_en%3AMarch&ati%5B5%5D=ati_organization_en%3AHealth%20Canada&ati%5B6%5D=ati_organization_en%3ANational%20Defence&ati%5B7%5D=ati_organization_en%3ANational%20Film%20Board&ati%5B8%5D=ati_organization_en%3AWestern%20Economic%20Diversification%20Canada&search_api_fulltext=&sort_by=year&sort_order=DESC&f%5B0%5D=ss_ati_organization_en%3AAtomic%20Energy%20of%20Canada%20Limited&page=8
    (Report an issue with citation)
About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 869 record(s)

Req # A-2022-001309

Adverse Drug Reactions (ADRs) for PATIROMER. Report numbers: E2B_05831606, E2B_05835686, E2B_05870970, E2B_05725256, E2B_05746902, E2B_05753092, E2B_05782219, E2B_05794284, E2B_05799758, E2B_05863711.

Organization: Health Canada

370 page(s)
March 2023

Req # A-2022-001310

Adverse Drug Reactions (ADRs) for SUCROFERRIC OXYHYDROXIDE. Report numbers: E2B_05817037, E2B_05720120, E2B_05747896, E2B_05751598, E2B_05775962, E2B_05778007, E2B_05782222, E2B_05795180.

Organization: Health Canada

49 page(s)
March 2023

Req # A-2022-001311

Adverse Drug Reactions (ADRs) for REXULTI, ARIPIPRAZOLE. Report numbers: E2B_05795715, E2B_05717142, E2B_05720816. ADR for REXULTI. Report number: E2B_05723433. ADRs for ABILIFY MAINTENA, ARIPIPRAZOLE. Report numbers: E2B_05724504, E2B_05717118.

Organization: Health Canada

139 page(s)
March 2023

Req # A-2022-001312

Adverse Drug Reactions (ADRs) for ABILIFY. Report numbers: 001011339, E2B_05756772, E2B_05716216, E2B_05723798, E2B_05728454, E2B_05789564, E2B_05789902, E2B_05828734, E2B_05804335, E2B_05828791.

Organization: Health Canada

149 page(s)
March 2023

Req # A-2022-001317

Adverse Drug Reactions (ADRs). Report numbers: 000994712, 001015384.

Organization: Health Canada

8 page(s)
March 2023

Req # A-2022-001318

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-112081-231.

Organization: Health Canada

4 page(s)
March 2023

Req # A-2022-001325

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-112870-971.

Organization: Health Canada

14 page(s)
March 2023

Req # A-2022-001331

Adverse Drug Reactions (ADRs) for KEYTRUDA. Report numbers: E2B_03277648, 000918127, E2B_03235688. ADRs for MMR II. Report numbers: E2B_02816266, E2B_02747299, E2B_02764074, E2B_01951549, 000720772, E2B_02640425, 000728010.

Organization: Health Canada

204 page(s)
March 2023

Req # A-2022-001338

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 22-112282-626.

Organization: Health Canada

27 page(s)
March 2023

Req # A-2022-001344

Adverse Drug Reactions (ADRs) for ALENDRONIC ACID. Report numbers: 000721030, E2B_01784693, E2B_01955555, E2B_01959932, E2B_02006413, E2B_02084296, E2B_02121367, E2B_02185793, E2B_02186544, E2B_02193826.

Organization: Health Canada

402 page(s)
March 2023
Date modified: